Search
for
Sort by
Research 391–420 of 1000+
- Clinical Manifestations of Hyperandrogenism and Ovulatory Dysfunction Are Not Associated with His1058 C/T SNP (rs1799817) Polymorphism of Insulin Receptor Gene Tyrosine Kinase Domain in Kashmiri Women with PCOS
- Synthesis, Characterisation, andIn VitroAnticancer Activity of Curcumin Analogues Bearing Pyrazole/Pyrimidine Ring Targeting EGFR Tyrosine Kinase
- Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors
- 1323 Human dermal fibroblasts and mast cell populations are altered in hidradenitis suppurativa, with epithelial-mesenchymal-transition signals ameliorated by spleen tyrosine kinase antagonism.
- Cerebral Ischemia Related to Isotretinoin; Venlafaxine-Induced Alopecia; Cognitive Dysfunction with Tolterodine; Retinal Artery Occlusion after Injection of Long-Acting Risperidone; Olanzapine-Induced Chylomicronemia Presenting as Pancreatitis; Metabolic Effects of the Atypical Antipsychotics – an Editorial; Another Drug-Induced Pancreatitis – This One Caused by a Tyrosine Kinase Inhibitor; Suicide Attempts Related to Antidepressant Medications
- Polymeric nanoparticles‐based topical delivery systems for the treatment of dermatological diseases
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- The PDGF/PDGFR pathway as a drug target
- Human hair melanins: what we have learned and have not learned from mouse coat color pigmentation
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Characterization of Human KAP24.1, A Cuticular Hair Keratin-Associated Protein with Unusual Amino-Acid Composition and Repeat Structure
- Regulation of microvascular permeability by vascular endothelial growth factors
- A Comprehensive Review on Skin Pigmentation-Types, Causes, and Treatment
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- The sheep KAP8-2 gene, a new KAP8 family member that is absent in humans
- A Case of Cicatricial Alopecia Associated with Erlotinib
- The Proteins of Normal and Aberrant Hair Keratins
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- β1 Integrins with Individually Disrupted Cytoplasmic NPxY Motifs Are Embryonic Lethal but Partially Active in the Epidermis
- Characterization and causal investigations of an alopecia syndrome in Australian fur seals (<i>Arctocephalus pusillus doriferus</i>)
- Loss of a homologous group of proteins in a dominantly inherited ectodermal malformation
- Protein and amino acid composition of hair from mice carrying the naked (<i>N</i>) gene
- Nilontinib induced keratosis pilaris atrophicans
- Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia
- Rapid hair depigmentation in patient treated with pazopanib
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- An overview of management of drug-induced hair and nail disorders
- Hair graying and loss induced by imatinib mesylate
- Gefitinib-induced hair alterations: Figure 1